Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).

Clinical trial NCT06581848 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06581848
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2025-06-05
Primary completion: 2030-01-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.